• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Competitive but Not Allosteric mTOR Kinase Inhibition Enhances Tumor Cell Radiosensitivity.竞争性而非变构的 mTOR 激酶抑制增强肿瘤细胞放射敏感性。
Transl Oncol. 2013 Jun 1;6(3):355-62. doi: 10.1593/tlo.13163. Print 2013 Jun.
2
The mTORC1/mTORC2 inhibitor AZD2014 enhances the radiosensitivity of glioblastoma stem-like cells.mTORC1/mTORC2 抑制剂 AZD2014 增强脑胶质瘤干细胞样细胞的放射敏感性。
Neuro Oncol. 2014 Jan;16(1):29-37. doi: 10.1093/neuonc/not139. Epub 2013 Dec 4.
3
The ATP-competitive mTOR inhibitor INK128 enhances in vitro and in vivo radiosensitivity of pancreatic carcinoma cells.ATP 竞争型 mTOR 抑制剂 INK128 增强胰腺癌细胞的体外和体内放射敏感性。
Clin Cancer Res. 2014 Jan 1;20(1):110-9. doi: 10.1158/1078-0432.CCR-13-2136. Epub 2013 Nov 6.
4
Combination of mTOR and EGFR kinase inhibitors blocks mTORC1 and mTORC2 kinase activity and suppresses the progression of colorectal carcinoma.mTOR 和 EGFR 激酶抑制剂的联合阻断了 mTORC1 和 mTORC2 激酶的活性,并抑制了结直肠癌的进展。
PLoS One. 2013 Aug 22;8(8):e73175. doi: 10.1371/journal.pone.0073175. eCollection 2013.
5
ATP-site binding inhibitor effectively targets mTORC1 and mTORC2 complexes in glioblastoma.ATP 位点结合抑制剂可有效靶向胶质母细胞瘤中的 mTORC1 和 mTORC2 复合物。
Int J Oncol. 2016 Mar;48(3):1045-52. doi: 10.3892/ijo.2015.3311. Epub 2015 Dec 28.
6
The dual mTORC1 and mTORC2 inhibitor PP242 shows strong antitumor activity in a pheochromocytoma PC12 cell tumor model.双mTORC1和mTORC2抑制剂PP242在嗜铬细胞瘤PC12细胞肿瘤模型中显示出强大的抗肿瘤活性。
Urology. 2015 Jan;85(1):273.e1-7. doi: 10.1016/j.urology.2014.09.020. Epub 2014 Nov 6.
7
Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2.mTOR的活性位点抑制剂靶向mTORC1和mTORC2的雷帕霉素抗性输出。
PLoS Biol. 2009 Feb 10;7(2):e38. doi: 10.1371/journal.pbio.1000038.
8
In vitro and in vivo radiosensitization induced by the ribonucleotide reductase inhibitor Triapine (3-aminopyridine-2-carboxaldehyde-thiosemicarbazone).核糖核苷酸还原酶抑制剂曲阿普明(3-氨基吡啶-2-甲醛缩氨基硫脲)诱导的体外和体内放射增敏作用
Clin Cancer Res. 2006 May 1;12(9):2912-8. doi: 10.1158/1078-0432.CCR-05-2860.
9
Dual mTORC1/2 inhibition in a preclinical xenograft tumor model of endometrial cancer.在子宫内膜癌的临床前异种移植肿瘤模型中双重抑制 mTORC1/2。
Gynecol Oncol. 2014 Feb;132(2):468-73. doi: 10.1016/j.ygyno.2013.11.027. Epub 2013 Dec 4.
10
Inhibition of the Translation Initiation Factor eIF4A Enhances Tumor Cell Radiosensitivity.抑制翻译起始因子 eIF4A 可增强肿瘤细胞的放射敏感性。
Mol Cancer Ther. 2022 Sep 6;21(9):1406-1414. doi: 10.1158/1535-7163.MCT-22-0037.

引用本文的文献

1
Inhibition of the Translation Initiation Factor eIF4A Enhances Tumor Cell Radiosensitivity.抑制翻译起始因子 eIF4A 可增强肿瘤细胞的放射敏感性。
Mol Cancer Ther. 2022 Sep 6;21(9):1406-1414. doi: 10.1158/1535-7163.MCT-22-0037.
2
Translation Initiation Machinery as a Tumor Selective Target for Radiosensitization.翻译起始机器作为肿瘤放射增敏的选择性靶点。
Int J Mol Sci. 2021 Oct 1;22(19):10664. doi: 10.3390/ijms221910664.
3
Improving the Efficacy of Tumor Radiosensitization Through Combined Molecular Targeting.通过联合分子靶向提高肿瘤放射增敏效果
Front Oncol. 2020 Aug 4;10:1260. doi: 10.3389/fonc.2020.01260. eCollection 2020.
4
Exploiting Radiation-Induced Signaling to Increase the Susceptibility of Resistant Cancer Cells to Targeted Drugs: AKT and mTOR Inhibitors as an Example.利用辐射诱导的信号来增加耐药癌细胞对靶向药物的敏感性:以 AKT 和 mTOR 抑制剂为例。
Mol Cancer Ther. 2018 Feb;17(2):355-367. doi: 10.1158/1535-7163.MCT-17-0262. Epub 2017 Aug 11.
5
Myc coordinates transcription and translation to enhance transformation and suppress invasiveness.Myc 协调转录和翻译以增强转化并抑制侵袭性。
EMBO Rep. 2015 Dec;16(12):1723-36. doi: 10.15252/embr.201540717. Epub 2015 Nov 4.
6
Radiation Enhancement of Head and Neck Squamous Cell Carcinoma by the Dual PI3K/mTOR Inhibitor PF-05212384.双PI3K/mTOR抑制剂PF-05212384对头颈部鳞状细胞癌的放疗增敏作用
Clin Cancer Res. 2015 Jun 15;21(12):2792-801. doi: 10.1158/1078-0432.CCR-14-3279. Epub 2015 Feb 27.
7
mTOR pathway in colorectal cancer: an update.结直肠癌中的mTOR信号通路:最新进展
Oncotarget. 2014 Jan 15;5(1):49-66. doi: 10.18632/oncotarget.1548.
8
The mTORC1/mTORC2 inhibitor AZD2014 enhances the radiosensitivity of glioblastoma stem-like cells.mTORC1/mTORC2 抑制剂 AZD2014 增强脑胶质瘤干细胞样细胞的放射敏感性。
Neuro Oncol. 2014 Jan;16(1):29-37. doi: 10.1093/neuonc/not139. Epub 2013 Dec 4.
9
The ATP-competitive mTOR inhibitor INK128 enhances in vitro and in vivo radiosensitivity of pancreatic carcinoma cells.ATP 竞争型 mTOR 抑制剂 INK128 增强胰腺癌细胞的体外和体内放射敏感性。
Clin Cancer Res. 2014 Jan 1;20(1):110-9. doi: 10.1158/1078-0432.CCR-13-2136. Epub 2013 Nov 6.

本文引用的文献

1
Distinct perturbation of the translatome by the antidiabetic drug metformin.二甲双胍对翻译组的显著干扰作用。
Proc Natl Acad Sci U S A. 2012 Jun 5;109(23):8977-82. doi: 10.1073/pnas.1201689109. Epub 2012 May 18.
2
mTOR signaling in growth control and disease.mTOR 信号在生长控制和疾病中的作用。
Cell. 2012 Apr 13;149(2):274-93. doi: 10.1016/j.cell.2012.03.017.
3
Targeting of mTORC2 prevents cell migration and promotes apoptosis in breast cancer.靶向 mTORC2 可防止乳腺癌细胞迁移并促进细胞凋亡。
Breast Cancer Res Treat. 2012 Aug;134(3):1057-66. doi: 10.1007/s10549-012-2036-2. Epub 2012 Apr 4.
4
Translation initiation factor eIF4E is a target for tumor cell radiosensitization.翻译起始因子 eIF4E 是肿瘤细胞放射增敏的靶点。
Cancer Res. 2012 May 1;72(9):2362-72. doi: 10.1158/0008-5472.CAN-12-0329. Epub 2012 Mar 7.
5
The translational landscape of mTOR signalling steers cancer initiation and metastasis.mTOR 信号转导的翻译景观指导癌症的发生和转移。
Nature. 2012 Feb 22;485(7396):55-61. doi: 10.1038/nature10912.
6
PI3K and mTOR signaling pathways in cancer: new data on targeted therapies.PI3K 和 mTOR 信号通路在癌症中的作用:靶向治疗的新数据。
Curr Oncol Rep. 2012 Apr;14(2):129-38. doi: 10.1007/s11912-012-0227-y.
7
Rapamycin passes the torch: a new generation of mTOR inhibitors.雷帕霉素传递火炬:新一代 mTOR 抑制剂。
Nat Rev Drug Discov. 2011 Oct 31;10(11):868-80. doi: 10.1038/nrd3531.
8
Oncogenic AKTivation of translation as a therapeutic target.致癌 AKT 对翻译的激活作为治疗靶点。
Br J Cancer. 2011 Jul 26;105(3):329-36. doi: 10.1038/bjc.2011.241. Epub 2011 Jul 19.
9
mTOR: from growth signal integration to cancer, diabetes and ageing.mTOR:从生长信号整合到癌症、糖尿病和衰老。
Nat Rev Mol Cell Biol. 2011 Jan;12(1):21-35. doi: 10.1038/nrm3025. Epub 2010 Dec 15.
10
Targeting eukaryotic translation initiation factor 4E (eIF4E) in cancer.针对癌症中的真核翻译起始因子 4E(eIF4E)。
Clin Cancer Res. 2010 Oct 15;16(20):4914-20. doi: 10.1158/1078-0432.CCR-10-0433. Epub 2010 Aug 11.

竞争性而非变构的 mTOR 激酶抑制增强肿瘤细胞放射敏感性。

Competitive but Not Allosteric mTOR Kinase Inhibition Enhances Tumor Cell Radiosensitivity.

机构信息

University of South Florida Morsani College of Medicine, Tampa, FL ; Radiation Oncology Branch, National Cancer Institute, Bethesda, MD.

出版信息

Transl Oncol. 2013 Jun 1;6(3):355-62. doi: 10.1593/tlo.13163. Print 2013 Jun.

DOI:10.1593/tlo.13163
PMID:23730416
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3660805/
Abstract

The mechanistic target of rapamycin (mTOR) is a critical kinase in the regulation of gene translation and has been suggested as a potential target for radiosensitization. The goal of this study was to compare the radiosensitizing activities of the allosteric mTOR inhibitor rapamycin with that of the competitive mTOR inhibitor PP242. On the basis of immunoblot analyses, whereas rapamycin only partially inhibited mTOR complex 1 (mTORC1) activity and had no effect on mTOR complex 2 (mTORC2), PP242 inhibited the activity of both mTOR-containing complexes. Irradiation alone had no effect on mTORC1 or mTORC2 activity. Clonogenic survival was used to define the effects of the mTOR inhibitors on in vitro radiosensitivity. In the two tumor cell lines evaluated, PP242 treatment 1 hour before irradiation increased radiosensitivity, whereas rapamycin had no effect. Addition of PP242 after irradiation also enhanced the radiosensitivity of both tumor lines. To investigate the mechanism of radiosensitization, the induction and repair of DNA double-strand breaks were evaluated according γH2AX foci. PP242 exposure did not influence the initial level of γH2AX foci after irradiation but did significantly delay the dispersal of radiation-induced γH2AX foci. In contrast to the tumor cell lines, the radiosensitivity of a normal human fibroblast cell line was not influenced by PP242. Finally, PP242 administration to mice bearing U251 xenografts enhanced radiation-induced tumor growth delay. These results indicate that in a preclinical tumor model PP242 enhances tumor cell radiosensitivity both in vitro and in vivo and suggest that this effect involves an inhibition of DNA repair.

摘要

雷帕霉素(mTOR)的机械靶标是调节基因翻译的关键激酶,已被认为是放射增敏的潜在靶点。本研究的目的是比较别构 mTOR 抑制剂雷帕霉素和竞争性 mTOR 抑制剂 PP242 的放射增敏活性。基于免疫印迹分析,雷帕霉素仅部分抑制 mTOR 复合物 1(mTORC1)活性,对 mTOR 复合物 2(mTORC2)没有影响,而 PP242 抑制了含有 mTOR 的两种复合物的活性。单独照射对 mTORC1 或 mTORC2 活性没有影响。集落形成实验用于定义 mTOR 抑制剂对体外放射敏感性的影响。在所评估的两种肿瘤细胞系中,PP242 在照射前 1 小时处理可增加放射敏感性,而雷帕霉素则没有作用。照射后添加 PP242 也增强了两种肿瘤系的放射敏感性。为了研究放射增敏的机制,根据 γH2AX 焦点评估 DNA 双链断裂的诱导和修复。PP242 暴露不影响照射后 γH2AX 焦点的初始水平,但明显延迟了辐射诱导的 γH2AX 焦点的分散。与肿瘤细胞系相反,正常人类成纤维细胞系的放射敏感性不受 PP242 影响。最后,在携带 U251 异种移植瘤的小鼠中给予 PP242 可增强放射诱导的肿瘤生长延迟。这些结果表明,在临床前肿瘤模型中,PP242 可增强肿瘤细胞的体外和体内放射敏感性,并表明这种作用涉及 DNA 修复的抑制。